Evidence map›Paper›PMID 27186114›Full record

ReviewJournal of experimental pharmacology2012

Hibiscus sabdariffa L., roselle calyx, from ethnobotany to pharmacology.

Octavio Carvajal-Zarrabal, Dulce María Barradas-Dermitz, Zaida Orta-Flores, Patricia Margaret Hayward-Jones, Cirilo Nolasco-Hipólito, M Guadalupe Aguilar-Uscanga, Anilú Miranda-Medina, Kopli Bin Bujang

Abstract readReview
In one paragraph

Review in Journal of experimental pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Plants (Basel, Switzerland) · 2021
    Article
  2. Organic Acids from Roselle (Biomedicines · 2020
    Review
  3. Article
  4. Beneficial Effects of Natural Bioactive Compounds fromMolecules (Basel, Switzerland) · 2019
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. ComparisonAvicenna journal of phytomedicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Octavio Carvajal-ZarrabalUniversity of Veracruz, Veracruz, Mexico.
Dulce María Barradas-DermitzVeracruz Institute of Technology, Veracruz, Mexico.
Zaida Orta-FloresVeracruz Institute of Technology, Veracruz, Mexico.
Patricia Margaret Hayward-JonesUniversity of Veracruz, Veracruz, Mexico.
Cirilo Nolasco-HipólitoUniversity of Malaysia Sarawak, Kuching, Malaysia.
M Guadalupe Aguilar-UscangaVeracruz Institute of Technology, Veracruz, Mexico.
Anilú Miranda-MedinaVeracruz Institute of Technology, Veracruz, Mexico.
Kopli Bin BujangUniversity of Malaysia Sarawak, Kuching, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using MEDLINE and SCOPUS databases, a review of the literature from the pioneering study of 1991 until 2010 was performed on the effects on biological models of Hibiscus sabdariffa L. roselle calyx, its extracts mainly in polar solvents, or pure components found in extracts, as well as their possible relationship to these effects. Three relevant effects on lipid metabolism, antihypertensive activity, and apoptosis were observed. Our chronological review of the studies mentioned in the literature provides another opportunity to see how humans compile scientific knowledge of a chemical structure-physiological activity relationship starting from an ethnobotanical-ethnopharmagognosy contribution. The chemical components that are the main active principles in the physiological activities of Hibiscus sabdariffa L. calyx are anthocyanins and polyphenols (protocatechuic acid and quercetin). Advances have also been made in the elucidation of action mechanisms. Additionally, it has become clear that the lack of standardization in terms of chemical components of the material arising from Hibiscus sabdariffa L. used in testing on biological models imposes limits on the possibility of carrying out comparative analyses between studies. Fortunately, more recent studies are overcoming this obstacle by reporting component concentrations of assumed active principles; however, complete analysis of the extract, if this is to be considered as a therapeutic agent, is not commonly reported in the aforesaid studies. If one of the eventual scenarios for Hibiscus sabdariffa L. calyx is as a therapeutic agent in communities with economic limitations, then studies of a pharmacological nature should guarantee the effectiveness, safety, and tolerability of this material, which is widely accepted to be associated with chemical complexity, thus making this knowledge necessary.

Indexed as

anthocyaninsantihypertensiveapoptosislipid metabolismphenolicpolyphenolic compoundssafe effective herbal therapeutic product

Identifiers

PMID27186114
PMCPMC4863543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.